These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 33099720

  • 1. ELK1 activated-long noncoding RNA LBX2-AS1 aggravates the progression of ovarian cancer through targeting miR-4784/KDM5C axis.
    Gu H, Lin R, Zheng F, Zhang Q.
    J Mol Histol; 2021 Feb; 52(1):31-44. PubMed ID: 33099720
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. NCK1-AS1 promotes NCK1 expression to facilitate tumorigenesis and chemo-resistance in ovarian cancer.
    Chang H, Li B, Zhang X, Meng X.
    Biochem Biophys Res Commun; 2020 Feb 05; 522(2):292-299. PubMed ID: 31761329
    [Abstract] [Full Text] [Related]

  • 8. LncRNA BBOX1-AS1 Aggravates the Development of Ovarian Cancer by Sequestering miR-361-3p to Augment PODXL Expression.
    Yao H, Chen R, Yang Y, Jiang J.
    Reprod Sci; 2021 Mar 05; 28(3):736-744. PubMed ID: 33159291
    [Abstract] [Full Text] [Related]

  • 9. LncRNA LBX2-AS1 facilitates abdominal aortic aneurysm through miR-4685-5p/LBX2 feedback loop.
    Li H, Zhang H, Wang G, Chen Z, Pan Y.
    Biomed Pharmacother; 2020 Sep 05; 129():109904. PubMed ID: 32559617
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA FEZF1-AS1 induced progression of ovarian cancer via regulating miR-130a-5p/SOX4 axis.
    Sun Z, Gao S, Xuan L, Liu X.
    J Cell Mol Med; 2020 Apr 05; 24(7):4275-4285. PubMed ID: 32135030
    [Abstract] [Full Text] [Related]

  • 11. LncRNA FGD5-AS1 promotes the malignant phenotypes of ovarian cancer cells via targeting miR-142-5p.
    Aichen Z, Kun W, Xiaochun S, Lingling T.
    Apoptosis; 2021 Jun 05; 26(5-6):348-360. PubMed ID: 33974163
    [Abstract] [Full Text] [Related]

  • 12. Roles of a TMPO-AS1/microRNA-200c/TMEFF2 ceRNA network in the malignant behaviors and 5-FU resistance of ovarian cancer cells.
    Li H, Zhou Y, Cheng H, Tian J, Yang S.
    Exp Mol Pathol; 2020 Aug 05; 115():104481. PubMed ID: 32497621
    [Abstract] [Full Text] [Related]

  • 13. LncRNA LOXL1-AS1 is transcriptionally activated by JUND and contributes to osteoarthritis progression via targeting the miR-423-5p/KDM5C axis.
    Chen K, Fang H, Xu N.
    Life Sci; 2020 Oct 01; 258():118095. PubMed ID: 32679142
    [Abstract] [Full Text] [Related]

  • 14. Long non-coding RNA LBX2-AS1 predicts poor survival of colon cancer patients and promotes its progression via regulating miR-627-5p/RAC1/PI3K/AKT pathway.
    Fang J, Yang J, Chen H, Sun W, Xiang L, Feng J.
    Hum Cell; 2022 Sep 01; 35(5):1521-1534. PubMed ID: 35816228
    [Abstract] [Full Text] [Related]

  • 15. Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis.
    Liu B, Yan L, Chi Y, Sun Y, Yang X.
    J Ovarian Res; 2021 Apr 29; 14(1):60. PubMed ID: 33926489
    [Abstract] [Full Text] [Related]

  • 16. LncRNA MNX1-AS1 promotes ovarian cancer process via targeting the miR-744-5p/SOX12 axis.
    Shen Y, Lv M, Fang Y, Lu J, Wu Y.
    J Ovarian Res; 2021 Nov 17; 14(1):161. PubMed ID: 34789303
    [Abstract] [Full Text] [Related]

  • 17. RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B.
    Wei X, Wang C, Tang S, Yang Q, Shen Z, Zhu J, Cheng X, Wang X, Xie X, Xu J, Lu W.
    J Zhejiang Univ Sci B; 2024 Jul 15; 25(7):581-593. PubMed ID: 39011678
    [Abstract] [Full Text] [Related]

  • 18. Upregulation of long noncoding RNA XIST has anticancer effects on ovarian cancer through sponging miR-106a.
    Guo T, Yuan D, Zhang W, Zhu D, Xiao A, Mao G, Jiang W, Lin M, Wang J.
    Hum Cell; 2021 Mar 15; 34(2):579-587. PubMed ID: 33400246
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.